[CALT] YoY Quarter Result on 30-Jun-2024 [#Q2]

Stock
[CALT] Calliditas Therapeutics AB (publ)
Announcement Date
13-Aug-2024
Financial Year
2024
Quarter
30-Jun-2024 [#Q2]
Profit Trend
QoQ- 80.71%
YoY- 48.36%
Quarter Report
CALT's Result
CALT's Financial Summary
View:
Show?
Quarter Result
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
Revenue 559,780 269,384 64,047 0 0 138,243 0 -
PBT -42,661 -70,660 -192,090 -165,212 -61,259 83,167 -18,185 15.25%
Tax 4,817 21,274 339 -2,140 67 17 0 -
NP -47,478 -91,934 -192,429 -159,840 -61,326 83,167 -18,185 17.32%
Tax Rate - - - - - -0.02% - -
Total Cost 607,258 361,318 256,476 159,840 61,326 55,076 18,185 79.35%
Ratio Analysis
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
NP Margin -8.48 -34.13 -300.45 0.00 0.00 60.16 0.00 -
Per Share
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
EPS -0.88 -1.71 -7.24 -6.40 -3.00 4.72 -1.08 -3.35%
EPS Diluted -0.88 -1.71 -7.24 -6.40 -3.00 4.70 -1.08 -3.35%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.